Trial Profile
Randomized Trial of the Efficacy, Safety, Tolerability and Pharmacokinetics of Dihydroartemisinin-piperaquine for Seasonal IPT to Prevent Malaria in Children Under 5 Years
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Amodiaquine; Pyrimethamine/sulfadoxine
- Indications Malaria
- Focus Adverse reactions; Therapeutic Use
- 29 Oct 2015 New trial record